{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:56Z","timestamp":1786985216254,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012554","name":"Hubei Provincial Department of Education","doi-asserted-by":"publisher","award":["D20221503"],"award-info":[{"award-number":["D20221503"]}],"id":[{"id":"10.13039\/100012554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019035","name":"Science and Technology Program of Hubei Province","doi-asserted-by":"publisher","award":["2024DJC062"],"award-info":[{"award-number":["2024DJC062"]}],"id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008869","name":"Wuhan Institute of Technology","doi-asserted-by":"publisher","award":["CX2024260"],"award-info":[{"award-number":["CX2024260"]}],"id":[{"id":"10.13039\/501100008869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807082"],"award-info":[{"award-number":["21807082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177090"],"award-info":[{"award-number":["22177090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109076","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:11:01Z","timestamp":1760001061000},"page":"109076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and evaluation of N-substituted indolyl-diazine derivatives as potent xanthine oxidase inhibitors"],"prefix":"10.1016","volume":"166","author":[{"given":"Shijian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109076_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the national kidney foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bioorg.2025.109076_bb0010","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1021\/acs.jmedchem.4c00136","article-title":"Discovery of a novel thienopyrimidine compound as a urate trans-porter 1 and glucose transporter 9 dual inhibitor with improved efficacy and favorable druggability","volume":"67","author":"Shi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0015","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1038\/s41467-024-49420-9","article-title":"Structural basis for urate recognition and apigenin inhibition of human GLUT9","volume":"15","author":"Shen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109076_bb0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2017.09.051","article-title":"Design, synthesis and biological evaluation of N-(4-alkoxy-3-cyanophenyl)isonicotinamide\/nicotinamide derivatives as novel xanthine oxidase inhibitors","volume":"141","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2024.114169","article-title":"Glucoconjugated monoterpene indole alkaloids with xanthine oxidase inhibitory activity from Ophiorrhiza japonica","volume":"224","author":"Shi","year":"2024","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2025.109076_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2018.10.012","article-title":"Gout \u2013 an update of aetiology, genetics, co-morbidities and management","volume":"118","author":"Robinson","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.bioorg.2025.109076_bb0035","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109076_bb0040","first-page":"1","article-title":"Uric acid and hypertension: a focused review and practical recommendations","volume":"37","author":"De Becker","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bioorg.2025.109076_bb0045","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.2174\/138161205774913219","article-title":"Uric acid and the kidney: urate transport, stone disease and progressive renal failure","volume":"11","author":"Capasso","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.109076_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2025.109076_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2017.04.031","article-title":"Anderluh, xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity","volume":"135","author":"\u0160melcerovi\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0060","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal tends: the national health and nutrition examination survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.bioorg.2025.109076_bb0065","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/14397595.2016.1170914","article-title":"Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting","volume":"26","author":"Lee","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bioorg.2025.109076_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioorg.2025.109076_bb0075","first-page":"380","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors, nature reviews","volume":"16","author":"Dehlin","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioorg.2025.109076_bb0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1517\/13543776.2011.577417","article-title":"Singh, xanthine oxidase inhibitors: a patent survey","volume":"21","author":"Kumar","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2025.109076_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cmdc.201900034","article-title":"Inhibitors of xanthine oxidase: scaffold diversity and structure-based drug design","volume":"14","author":"Luna","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109076_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: one enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2025.109076_bb0095","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/cbdd.14319","article-title":"Therapeutic voyage of synthetic and natural xanthine oxidase inhibitors","volume":"102","author":"Agrawal","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109076_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103564","article-title":"Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: design, synthesis and biological evaluation","volume":"95","author":"Gao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0105","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/med.21457","article-title":"Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases","volume":"38","author":"Kumar","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.109076_bb0110","doi-asserted-by":"crossref","unstructured":"E. K\u0131br\u0131z, M. Sa\u00e7mac\u0131, \u0130. Y\u0131ld\u0131r\u0131m, S. Abbas Ali Noma, T. Ta\u015fk\u0131n Tok, B. Ate\u015f, Xanthine oxidase inhibitory activity of new pyrrole carboxamide derivatives: In vitro and in silico studies, Arch. Pharm. 351 (2018) e1800165. doi:10.1002\/ardp.201800165.","DOI":"10.1002\/ardp.201800165"},{"key":"10.1016\/j.bioorg.2025.109076_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003095","article-title":"Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: a randomized, controlled trial","volume":"17","author":"Tanaka","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.bioorg.2025.109076_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.07.062","article-title":"Targeting the subpocket in xanthine oxidase: design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0125","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109076_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jcpt.12392","article-title":"Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study","volume":"41","author":"Hosoya","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2025.109076_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106064","article-title":"A possible covalent xanthine oxidase inhibitor TS10: inhibition mechanism, metabolites identification and PDPK assessment","volume":"128","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116443","article-title":"Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors","volume":"271","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0145","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ejmech.2014.12.013","article-title":"Novel pyrazole-5-carboxamide and pyrazole\u2013pyrimidine derivatives: synthesis and anticancer activity","volume":"90","author":"Shi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2019.02.014","article-title":"Anti-inflammatory drug approach: synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds","volume":"86","author":"Atatreh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114946","article-title":"Pyrimidine derivatives with antitubercular activity","volume":"246","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113928","article-title":"Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5\/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors","volume":"227","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116117","article-title":"Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site","volume":"38","author":"Sun","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.07.061","article-title":"Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano) phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors","volume":"181","author":"Mao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2015.08.056","article-title":"Synthesis and evaluation of 1-hydroxy\/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors","volume":"103","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116893","article-title":"Design, synthesis, and evaluation of chalcone derivatives as xanthine oxidase inhibitors","volume":"279","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1039\/C8MD00512E","article-title":"Benzoflavone derivatives as potent antihyperuricemic agents","volume":"10","author":"Singh","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2025.109076_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105417","article-title":"Amide-based xanthine oxidase inhibitors bearing an N-(1-alkyl-3-cyano-1H-indol-5-yl) moiety: design, synthesis and structure-activity relationship investigation","volume":"117","author":"Zhang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aac.2024.09.004","article-title":"Discovery of 4-hydroxyphenylpyruvate dioxygenase inhibitors with novel pharmacophores","volume":"3","author":"Yang","year":"2024","journal-title":"Adv. Agrochem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0200","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzymeinhibitor complex and mechanism of inhibition","volume":"278","author":"Okamoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129286","article-title":"Identification of natural xanthine oxidase inhibitors: virtual screening, anti-xanthine oxidase activity, and interaction mechanism","volume":"259","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109076_bb0210","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel human urate transporter 1 inhibitors as hypouricemic drug candidates with favorable druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109076_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114947","article-title":"Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors","volume":"246","author":"Peng","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:51Z","timestamp":1777463991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S0045206825009563"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109076","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of N-substituted indolyl-diazine derivatives as potent xanthine oxidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109076"}}